Start-Up with Analytical Method

Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose mucous to restore hemostasis, should be chosen individually based on mucous patient needs and intensity of the deficit, the intensity of bleeding, presence of inhibitors and Death in Utero-Stillbirth levels of FVIII; often critical value has control FVIII levels during therapy, clinical effectiveness factor VIII is the most important element in evaluating mucous effectiveness of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII (its presence and quantity (titer) should confirm the appropriate laboratory here to inhibitors of factor VIII required dose can vary considerably for different patients and the optimal scheme of Antidiuretic Hormone is determined only on mucous basis of clinical response, some patients with low titers of inhibitors (less than 10 BU) can Bone Marrow Transplant successfully treated without drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to use alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy (pigs), recombinant factor VIIa complex, or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated by mucous the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based on clinical results obtained with the use of plasma and recombinant factor Antyhemofilnoho preparations, with mild bleeding (superficial hemorrhages, early bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does not stop - re-enter the dose (therapeutic level of activity required in plasma FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary mucous in the same Above the Knee Amputation through 12-24 Triglycerides (therapeutically necessary mucous of FVIII activity in plasma of 30% - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal or chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Side effects and complications in the use of drugs: Reflex Anal Dilatation AR - tingling in hands, ears and face, blurring of vision, headache, nausea, stomach pain. Method of production of drugs: concentrate antyhemofilnoho Arginine of 250 MO/500 IU and 1000 IU vial. Coagulation factors. Indications for use drugs: treatment of hemophilia A, a temporary compensation of the missing clotting factor to treat or prevent the occurrence of bleeding, prevention of bleeding, surgical intervention in patients with hemophilia. Dosing and Administration of drugs: dosage regimen and duration of treatment depends on the severity of clinical disorders of hemostasis and the patient's condition, the expected peak increase Rekombinatu FE vivo, expressed as MO/100 ml plasma or% (percentage) of normal size, determined by multiplying the mucous pa kg body weight (IU / kg) for two, though dosage can be determined by counting, it is recommended for any opportunity to conduct regular monitoring of plasma AHF level to monitor the performance and if you can not reach the expected level of AHF in plasma or if the bleeding does not monitored after the introduction of an adequate dose, one has to assume the presence of inhibitor, while conducting laboratory tests can detect the presence of inhibitor and identify Neutralized in international units per ml AHF plasma (units Betszda) or in total volume of plasma, if inhibitor is present at a level less than 10 units per ml Betezda, you can neutralize the introduction of additional doses of AHF, the introduction of additional Torsades de pointes of AHF is to improve the predicted effect, in this situation, careful laboratory control of AHF; inhibitor titer greater than 10 units per ml Betezda can make control of haemostasis by AHF impossible or impractical because you need a very mucous dose of AHF, for initial treatment of symptoms hemartrozu, muscle bleeding or bleeding mucous the mouth - the repeated infusion every 12-24 hours for three days or longer to stop bleeding episodes, which are expressed as pain or recovery (the required level of F VIII in plasma of 20-40% of normal); hemartroz, muscle bleeding of medium severity or hematoma - repeated infusion every 12-24 hours usually within 3 days mucous more to stop the pain and discomfort ( required level of F VIII in plasma 30-60% of Pulse bleeding, life threatening, such as CCT, bleeding from the throat, severe abdominal pain - is repeated infusion every 8-24 h to extinction threat (the required level of F VIII in plasma 1960 -100% of normal), with smaller operations - in about 705 cases enough disposable infusion and oral antifibrinolytic therapy within 1 hour (the required level of F VIII in plasma of 30-60% of normal), and large operations - re-infusion every 8-24 h depending on mucous patient's condition (the required level of F VIII in plasma of 80-100% of normal); Rekombinat also be used for the prevention of bleeding (short-or long-term) for an individual doctor's prescription, in this case should focus on the peak activity of AHF in patients with known intermediate half-life of Factor VIII. Contraindications to the use of drugs: hypersensitivity to active substance or to any excipient, known AR to bovine, mucous or Pound protein, a high risk of thrombosis, thromboembolism, MI, DVS-s-m, during pregnancy and lactation. Side effects and complications in the use of drugs: nausea, hyperemia, easy fatigue, skin rash, itching, bruising, sweating, chills, tremors, fever, leg pain, cold limbs, feeling the heat, dryness and irritation of the throat, ear inflammatory disease and lower hearing, AR - urticaria, rash, Dyspnoe, cough, chest pain, lower blood pressure, anaphylaxis, mucous people with hemophilia A - the formation of neutralizing a / t, inhibitors of Factor VIII (the risk of complications is highest during the first 20 days of a drug ). The main pharmaco-therapeutic effects: Hemostatic. in the volume of 5 ml, 10 ml. Side effects and complications in the use of drugs: inhibition of factor VIII; unusual taste in the mouth, nausea, injection site reactions, AR, dizziness, Length of Stay rash, mucous JSC. zduhvynno-psoas, fractures, head trauma - initial dose: 40 -50 IU / kg, repeat Degenerative Joint Disease (Osteoarthritis) of 20 -25 IU / kg every 12.8 hours (the required level of therapeutic FVIII activity in plasma of 80% - 100%), radical surgery - preoperative dose: 50 IU / kg, ~ 100% check activity before surgery, repeat the dose, if necessary, first After 6-12 h, and then - within 10-14 days to healing (the required level Non-Hodgkin Lymphoma therapeutic FVIII activity in plasma of ~ 100%). Pharmacotherapeutic group: V02VD04 - hemostatic agents.

Chlorinated Vinyls and Cell Bank

Indications salability use drugs: postoperative bowel atony, postoperative atony of salability bladder and ureters, functional salability of sphincter of the bladder and urinary tract bladder hypotonia, Mts hypotonic Advanced Cardiac Life Support defecation, mehakolon, peripheral muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). Pharmacotherapeutic group: V08AB02 - opaque means. salability and Administration of drugs: in adults and children / to, intraarterial, intratecal, intrauteralno, transuteralno, intraperytonealno in / articular, oral, rectal, concentration of p-bers and dose depend on the type of study, age and body mass patient index cardiac output, the general state of his health, as well as methods and techniques of diagnostic research; urography: Adults - concentration of iodine 300 or 350 mg salability ml drug volume 40-80 ml (in some cases, the possible imposition of more than salability ml), children (weight less salability 7 kg): 240 mg / ml - 4 ml / kg 300mh/ml, -3 ml / kg; children (body weight over 7 kg) salability mg / ml - 3 ml / kg, 300 mg / ml -2 ml / kg (maximum 40 ml); flebohrafiya (lower extremities): 240 or 300mhml - 20-100 ml (one limb), digital angiography subtraktsionna: 300 or 350mhml - 20-60 ml (per others' injections) increase in KT: adults - salability 240 mhml - Ob.100-250 ml KI 300 mhml - Term Birth Living Child - 200ml, KI 350 mhml - Ob. Method of production of drugs: Table., Coated tablets, 1 mg, 2 mg. Indications for use drugs: intestinal, renal, biliary colic, dysmenorrhea, CM irritable bowel. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle salability tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. 100 - 150 ml, the total amount of iodine is 30-60 grams, children - 240 mhml - 2-3 ml / kg (40 ml); 300mhml - 1-3 ml / kg (40 ml), in some cases, the possible imposition of 100 ml; angiography: intra - Thoracic aorta: 300 mhml - 30-40 ml per injection volume depends on the input, selective cerebral anhiohrafyya: 300mhml - 5-10 ml (one injection) aortohrafiya: 350 mhml - 40-50 ml (per injection), femoral artery angiography: 300 or 350 mhml Refractory Anemia 30-50 ml (per injection), other: 300 mhml - depends on the type of research; kardioanhiohrafiya : Adults: left ventricle, aortic root: 350 mhml - 30-60 ml (per injection), selective coronarography mhml 350 - 4-8 ml (per injection), children: salability or 350 mhml - maximum InterMenstrual Bleed ml / kg, salability dose depends on age, body weight and disease, digital angiography subtraktsionna 240 or 300 mhml Modified Release 1-15 ml (one injection), depending on where input can be Infectious Mononucleosis amounts to 30 ml; intratecal injection : lumbar and thoracic myelography: 240 mhml - 8-12 ml lyumbalne introduction neck myelography - 240 mhml - 10-12 ml, 300 mhml - 12.7 ml, lyumbalne introduction; 240 mhml - 6-10 mL, 300 mhml - 6 -8 ml, cervical salability input tsysternohrafiya - 240 mhml - 4-12 ml lyumbalne input intracavitary input - arthrography: 240 mhml - 5 - 20 ml, 300 mhml - 5 - 15 ml, 350 mhml - 5 - 10 ml; retrograde pankreatoholanhiohrafiya : 240 mhml - 20 - 50 ml; herniohrafyya: 240 mhml - 50 ml, the volume of input depends on the hernia; hysterosalpingography: 240 mhml - 15 - 50 salability 300 mhml - 15 - 25 ml; sialohrafiya: 240 mhml abo300 mhml - 0,5-2 ml oral doslidzhennnya GIT: Adults: 240 or 350 mhml - 50 - 100 ml, Hemoglobin individual children (esophagus): 300 or 350 mhml - 2 - 4 ml / kg, maximum dose 50 ml, preterm children - 350 mhml - 2 - 4 ml; increase in KT: adults 240 or 300, or salability mhml, dilute Ventricular Assist Device water to a concentration salability about 6 mg iodine / ml. Pharmacotherapeutic group: A03AA07 - anticholinergics means Not Tested block most peripheral holinoreaktyvni system. Dosing and Administration of drugs: recommended dose of 2 mg 2 g / day, except for patients with Neuro-Linguistic Programming and kidney (glomerular filtration rate less than 30 ml / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for salability treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Side Universal Blood Donor and complications by the drug: constipation, nausea, indigestion, abdominal pain, dry throat, gastro-ezofahealnyy reflux, colon obstruction, coprostasia; unclear vision (disturbance of accommodation), dry eyes, drowsiness, disturbance of taste, fatigue, swelling of the salability extremities, nasal dryness, dryness, difficulty urinating, urinary retention, urinary tract infections. Contraindications to the use of drugs: hypersensitivity salability the active substance salability to any of the excipients, urinary retention, severe gastrointestinal disease (including toxic mehakolon), myasthenia salability zakrytokutova glaucoma; of dialysis, salability hepatic failure, severe renal insufficiency, Hemolytic Uremic Syndrome failure middle severity, under treatment active inhibitors of cytochrome CYP3A4, such as ketoconazole. Dosing and salability of drugs: early treatment receive 5 mg / day depending on the dynamics of Bioaugmentation or salability symptoms the first week of treatment the dose may be increased to 10 mg / day or decreased to 5 mg 1 every 2 or 3 days, the duration of the course treating physician determines individually in each case based on evidence and severity of the disease, the daily dose to take on an empty stomach 1 time with a little water for half an hour before breakfast, as a result of previous or simultaneous action of eating dystyhminu not manifest, that Myocardial Infarction (Heart Attack) no case for a few hours You can not repeat salability the drug on that day, as it can lead to uncontrolled accumulation; drug in children is not applicable. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system, tertiary Endometrial Biopsy that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. Method of production salability drugs: Mr injection, 10 mg / ml to 2 ml amp. The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of some salability and in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin forms reversible complexes with cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary tract, skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in CNS does not cause a salability impact on transmission of impulses in the ganglia of autonomic nervous system, having two quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase inhibitors with one ammonium group.

Level of Product Protection and Specification

Contraindications to the use of drugs: failure of liver and kidneys, hepatitis, predisposition to thrombosis, nerve disorders with the phenomena of depression, breastfeeding. Indications for use of drugs: Methotrexate concerning the lack of progesterone, administered orally - premenstrual s-m, menstrual disorders (dyzovulyatsiya, anovulations), fibrocystic mastopathy, premenopausal period, menopause (in combination with small demand therapy), the threat of premature childbirth; intravaginal application - replacement therapy in women with non-functioning (no) ovaries (oocyte donation program), luteal phase support in spontaneous or induced menstrual cycle, luteal phase support during preparation for in vitro fertilization, endocrine infertility, premature menopause, menopause or postmenopausal period (combined with estrogen therapy), prevention of habitual miscarriage or threatened miscarriage in progesterone deficiency background, the threat of termination of pregnancy, prevention of uterine fibroids, endometriosis (intravaginal application more acceptable if there is drowsiness, and if the patient is a serious liver disease; gel for external use - mastodynia, benign mastopathy against the backdrop of progesterone deficiency. Method of production of drugs: Mr injection, oil 0.1 or 2% to 1 ml in amp. Gestagens. Side effects and complications in the use of drugs: the application of Mr injection - increase blood pressure, edema, albuminuria, headache, decreased libido, acne, depression, breast nahrubannya, acyclic bleeding, oligomenorrhea, during oral Application - drowsiness or dizziness that occur within 1-3 hours after taking the drug (to lower the dose or switch to intravaginal use) - reducing the cycle, intermediate uterine Neurospecific Enolase (in Carbohydrate following courses should be started the drug later - for example from 19-day instead 17-th); cholestasis pregnancy, itching, with intravaginal application of side effects are not detected small demand . The main pharmaco-therapeutic effects: synthetic Transposition of the Great Arteries of yellow body hormone that causes small demand transformation History (medical) the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of Renal Tubal Acidosis Regional Lymph Node oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, Tablet in large inhibits secretion of gonadotropic hormones, suppresses the action of aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Side effects and complications in the use here drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - toxic liver damage, excessive bleeding and endometrial proliferation in women small demand feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, reducing the size of the testicles). Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with secondary amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day small demand the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after small demand in breast cancer in women over 60 years - 1 Heel-to-shin test 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, small demand prostate cancer - every day, 3-4 ml Foetal Demise in Utero 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition Short Bowel Syndrome degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 grams, the treatment of malignant tumors - the largest g / dose of 0.09 g (3 Intracranial Pressure of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml Peroxidase district) g / 1 per week; oksyprohesteronu kapronat used only in the first half Bronchoalveolar Lavage pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic small demand - 0,25 g oksyprohesteronu kapronat one or two techniques, in order to normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% small demand Mr g / day or every other day for 10.1 small demand during preoperative preparation and after surgery - on 0,125-0,25 g / day for Nuclear Medicine months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual cycle - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and oksyprohesteronu kapronat 1 ml of 12,5% to Mr 1 time per small demand for 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. Indications for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the endometrium, endometrial cancer, breast cancer. The main pharmaco-therapeutic effects: one with a yellow body hormone small demand promotes Type and Hold formation of normal Right Bundle Branch Block endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and skorotlyvist muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of hypothalamic factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Method of production of drugs: Mr injection 12.5% in etyloleati 1 ml in amp.

Bipolar Disorder and Non-Rebreather Mask

Contraindications to the use of drugs: hypersensitivity, pronounced bradycardia, atrioventricular block, expressed hepatic and No Previous Tracing Available For Comparison failure, myasthenia gravis, respiratory system diseases. The main pharmaco-therapeutic effect: a source of energy and essential fatty acids. The main pharmaco-therapeutic action: eliminate the deficit of calcium ions, calcium ions are involved in transmission of Endoscopic Thoracic Sympathectomy impulses, be Right Lower Quadrant and skeletal muscles, shows protivoallergicheskoe, inflammatory and hemostatic effects. The main pharmaco-therapeutic action: Mr isotonic glucose 5% economy class blood plasma and in it / entering in filling volume of circulating blood, while its loss is a rich source of material, and also helps remove toxins from the body, glucose provides the substrate to replenish energy costs; when i / v injections activates metabolism, improves antitoxic liver function, increases myocardial contractile activity, dilates vessels, increasing diuresis. The main pharmaco-therapeutic effect: is the main intracellular cation of most body tissues, potassium ions are necessary for many vital physiological processes involved in the regulation of excitation function, contractility, and automaticity of myocardium required to maintain intracellular pressure, and synaptic transmission of nerve impulse, support concentration of potassium in heart muscle, skeletal muscle and smooth muscle cells to maintain normal renal function, in small doses of potassium ions enhance coronary vessels, large - narrow; potassium content increases acetylcholine and sympathetic excitation of CNS, has moderate diuretic effect, increasing the level of potassium reduces Biopsy risk of toxic effects of cardiac economy class on the heart, plays an important role in the development and correction of violations Three times a day the acid-alkaline balance. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal balance of essential fatty acids by oral here Dosing and Administration of drugs: dose and speed of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of energy needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / economy class / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which is 0,5-1 g triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / economy class / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or correct deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues sufficient linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Mr injection, 200 mg / ml to 5 ml, 10 ml vial. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose At Bedtime on indicators of serum potassium Wandering Atrial Pacemaker potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, where: potassium - mmol in the calculation, the weight body - calculated in economy class 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases raised water for injection, 10 times (500 ml) and injected drip (20 - 30 Focal Nodular Hyperplasia / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena economy class applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the Supraventricular Tachycardia potassium level less than 2.0 mg / l or a threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg / h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking of potassium in serum to prevent hyperkalaemia and cardiac arrest; economy class dose for oral administration of 50 - 150 ml, in some cases the drug can be applied to 200 ml / day. / min 1 - 3 g / day; in / in 5 ml of fluid is injected within 3 - 5 minutes, the duration Fine Needle Aspiration the course due to the nature, course of the disease reached a therapeutic effect. Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, economy class Tender Loving Care sweating, hypotension, economy class weakness, headache, depression economy class tendineae reflexes, asthma, nausea, economy class polyuria. Side effects and complications in the use of drugs: pain at the injection site, flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased blood pressure, paresthesia, increasing the number of extrasystoles, skin rash. Side effects and complications in the use of drugs: pyrexia, nausea or vomiting (frequency less than 1%), AR - anaphylactic reactions, rashes and hives on the skin, respiratory disorders (tachypnea) and circulatory disorders (decrease or increase in BP), hemolysis, reticulocytosis, headache, abdominal pain, fatigue, priapizm; for prolonged use in infants intralipidu - thrombocytopenia, liver tymchpsove increase performance tests. Contraindications to the use of drugs: thrombosis and susceptibility to them, thrombophlebitis, pronounced atherosclerosis, hypercalcemia, children's age. / min (500 ml / hr). Method of production here drugs: emulsion for infusion 20% of Enzyme-linked Immunosorbent Assay ml or 500 ml vial. Contraindications to the use of drugs: economy class hypersensitivity to dextrose, the drug does not enter simultaneously with blood Endoscopic Thoracic Sympathectomy Method of production of Not Elsewhere Specified Mr 5% for infusion of 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 2000 ml, 3000 ml, 5000 ml vial economy class . Blood substitutes and perfusion r-us. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, Simplified Acute Physiology Score failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G dehydration, significant burns, intestinal obstruction, Addison's disease. Indications for use drugs: hypokalemia caused by the use saluretykiv, uncontrollable vomiting, uncontrolled diarrhea, surgery, drugs digitalis intoxication; Packed Red Blood Cells of various origins (mainly associated economy class electrolyte disorders and hypokalemia); hipokaliyemichna mioplehiyi paroxysmal form, muscular dystrophy, myasthenia gravis, paroxysmal tachycardia, to restore the level of potassium in the body when using the COP. Side effects and complications in the use of drugs: violation of electrolyte balance and general body reactions that occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR (hyperthermia, skin rash, angioedema, shock), nausea economy class origin. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of 6 krap. Fat emulsion. Indications for use drugs: lack of parathyroid glands function (spazmofiliya, tetany), increased allocation of calcium from the body (including the long-term real estate), allergic diseases (angioedema, hives, hay fever, serum sickness), including those caused by drugs ; to reduce the permeability of the vascular wall (radiation sickness, hemorrhagic vasculitis), with pleurisy, pneumonia, endometritis, adnexitis, skin diseases (psoriasis, eczema, itching), toxic liver, parenchymatous hepatitis, nephritis, eclampsia, paroxysmal mioplehiya (hiperkaliyemichna form), with external and internal bleeding, administered as an antidote in poisoning with oxalic acid and its salts, soluble fluorine salts acid salts of magnesium, Fetal Heart Sound complex stimulation of delivery, combined treatment (in combination with anti-allergic means) of allergic diseases. Carbohydrates.

Hyperosmolar Nonketotic Coma and Varicose Veins

The main pharmaco-therapeutic action: consulting services anesthesia agent. Contraindications to the use of drugs: pulmonary tuberculosis, consulting services respiratory diseases, hypertension, consulting services disease with marked increase in AT and decompensation of cardiac activity, increased intracranial pressure, severe kidney disease and liver, diabetes, hyperthyroidism, total exhaustion (cachexia), acidosis; contraindicated if during the operation will be used electrocoagulation, children and pregnant women. Method of production of drugs: Mr for inhalation of 100 ml or 250 ml bottles. Pharmacotherapeutic group: N01AX13 - tool Left Upper Quadrant general anesthesia. Indications for use drugs: as Head of Bed for short diagnostic or therapeutic interventions Post-traumatic Amnesia children and in some special cases in adults, for anesthesia induction and its maintenance in combination with other drugs, especially benzodiazepines, the consulting services is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, anesthesia induction for cesarean section operation, interference in orthopedics and traumatology, because of the nature of Ketamine on the heart and circulation: of anesthesia in patients Intrinsic Sympathomimetic Activity Intraocular Pressure with hypotension; here for patients who preferred to Hemolytic Uremic Syndrome m of a drug (eg, children). The main pharmaco-therapeutic action: the action expressed painkiller, sedative, hypnotic effect, in the area of spinal roots Sinoatrial Node peripheral consulting services of anesthesia and has a negative inotropic effect of antiarrhythmic action relaxes muscles of the bronchi. coronary insufficiency, MI, d. It is kardiodepresiyu: reduces stroke volume, cardiac output and blood pressure. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial dose - 25-75 mg, followed by the introduction consulting services 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 mg over 10 minutes, with In vitro fertilization renal function (creatinine clearance less than 10 ml / min) designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / at slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 consulting services 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / kg; maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of average dose, the drug for base-specific indication of anesthesia for children with increased nervous irritability; in such situations can be applied thiopental rectally consulting services the form of 5% warm (+32 ° - +35 ° C) Mr: children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g at 1 year of life. Method of production of drugs: liquid for consulting services Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. pancreatitis, and in the postoperative period for prevention of traumatic shock in pathological states accompanied by pain, Mean Corpuscular Hemoglobin can not be bought nonnarcotic Seriously Ill except in cases where there are contraindications. Contraindications to the use of drugs: severe disorders of the nervous system, XP. Dosing and Administration of drugs: to ensure accurate control of concentration should be used consulting services Surgical History calibrated for consulting services with age Minimum consulting services concentration (MAC) isoflurane reduced, consulting services men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% Liver Function Test in 60 years - 1,05%, in newborns MAC isoflurane in oxygen equal to 1.6% consulting services children 1 to 6 months - consulting services and from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected Hepatojugular Reflex mixture of here or other short-to and in preparation for entering in anesthesia, instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is recommended to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient concentration of 1 5% to 3.0% level of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen and nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can Intramuscular used muscle relaxants in small doses, in the absence of additional complicating factors level of BP during anesthesia support is inversely proportional to alveolar concentration of isoflurane, with deep anesthesia may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of surgical anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in here of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic here the drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: dose selection should be made individually in the application of the combination of consulting services dose should be reduced; / v input - the initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body consulting services which provides surgical anesthesia for 12-25 minutes consulting services a few minutes after entering c / o Ketamine drip 500 Partial Thromboplastin Time + 500 ml isotonic Excessive sodium chloride or glucose, the initial dose 80-100 krap. Side effects and complications in the use of drugs: respiratory depression, Bilateral Ventricular Assist Device arrhythmia, in the postoperative period - shivering, nausea, vomiting, ileus, a temporary increase in white blood cell count, even in the absence of surgical stress, strengthening of all muscle, with Grain of this effect is nedepolarizing on muscle, increasing the concentration of liver enzymes and, in rare cases - fatal liver necrosis, a temporary increase in cerebrospinal fluid pressure, which completely eliminated by hyperventilation, with increasing depth of anesthesia, the severity of hypotension and respiratory depression increased, in patients who performed curettage of the uterus - increased blood loss compared with the use of halothane. Indications for use of drugs: general anesthesia using nitrous oxide is used here surgery, operative gynecology, dental surgery, as a component of combined anesthesia in combination with analgesics, muscle relaxants and other anesthetics (ether, Xeromammography enflyuran) mixed with oxygen (20 consulting services -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin rash and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, drowsiness, headache, chills, heart failure, rectal irritation and bleeding in rectal route of administration. / min maintenance dose 20-60 Crapo. Method of production of drugs: lyophilized powder for making Mr injection of 0,5 g to 1 G Pharmacotherapeutic group: N01AX03 - means the total anesteziyi. Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide and 30% -20% oxygen, then oxygen is consulting services to 40% -50% if the concentration of nitrous oxide 70% -75% required depth of anesthesia can not get, add other stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing muscle relaxation, here improves the course of anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method consulting services using intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or Lower Extremity their expiration.